Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cumbre Inc. and collaborator publish on a novel bacterial RNA polymerase inhibitor

24.10.2003


Cumbre Inc. and University of Wisconsin-Madison research collaborator publish data on a new class of bacterial RNA polymerase inhibitor



Cumbre Inc., a privately held biopharmaceutical company, announced today the publication of a research paper in the October 24, 2003 issue of Science entitled "A new class of bacterial RNA polymerase inhibitor affects nucleotide addition." The paper describes the identification and characterization of the novel "CBR703" class of inhibitors through combined efforts in biochemistry, genetics and structural modeling with contributions from both Cumbre researchers and scientists from the University of Wisconsin-Madison.

Co-author Robert Landick, Ph.D., a Professor of Bacteriology at the University of Wisconsin-Madison, whose laboratory is primarily focused on studies of regulatory mechanisms that control gene expression in bacteria, commented, "The Cumbre RNA polymerase inhibitors are a major breakthrough. They give us a powerful new tool to study the mechanism of the central enzyme in the process of gene expression. At least as importantly, they also hold great promise for the development of new antibiotics that target bacterial pathogens, which is now a high-priority need in both medicine and bio-defense."


A. Simon Lynch, Ph.D., Cumbre’s Director of Research, added "We are excited about the development potential of the CBR703 series, and are pleased to be able to contribute to the RNA polymerase research community through provision of a novel experimental tool. We hope that ongoing efforts to determine high resolution X-ray structures of RNA polymerase-inhibitor complexes will both aid Cumbre’s antibiotic development program and yield additional insight regarding the fundamental processes underlying the transcription elongation cycle."

Cumbre, a privately held biopharmaceutical company founded in February 2001, is solely focused on the discovery, development, and commercialization of novel antibacterial therapeutics. Discovery programs combine unique target-directed biochemical screens with a novel cell-based approach. The most advanced development program is directed toward the optimization of a novel compound series for activity against pathogenic bacteria growing in the biofilm state.

Robert England | EurekAlert!
Further information:
http://www.cumbre.biz

More articles from Life Sciences:

nachricht Nonstop Tranport of Cargo in Nanomachines
20.11.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik

nachricht Researchers find social cultures in chimpanzees
20.11.2018 | Universität Leipzig

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nonstop Tranport of Cargo in Nanomachines

Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.

Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

Nonstop Tranport of Cargo in Nanomachines

20.11.2018 | Life Sciences

Researchers find social cultures in chimpanzees

20.11.2018 | Life Sciences

When AI and optoelectronics meet: Researchers take control of light properties

20.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>